OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
20 hedge funds and large institutions have $1.75M invested in OncoSec Medical Incorporated in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
23% less capital invested
Capital invested by funds: $2.26M → $1.75M (-$509K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$93.4K |
| 2 |
VF
Virtu Financial
New York
|
+$48.4K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$42.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$12.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$11.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$279K |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$40K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$12K |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$3K |
| 5 |
Bank of New York Mellon
New York
|
-$1.34K |
ONCS Hedge Fund Activity: Q3 2017 in Review
20 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2017, worth a combined $1.75M — down 23% from $2.26M a quarter earlier.
Fund positioning in ONCS was balanced in Q3 2017: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Zurich Cantonal Bank, opening a new position worth an estimated $93.4K. The largest seller was Millennium Management, exiting entirely with an estimated $279K sold.
- 20 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $1.75M of OncoSec Medical Incorporated stock for Q3 2017, down 23% quarter-over-quarter.
- 4 funds opened new OncoSec Medical Incorporated positions in Q3 2017 and 4 closed out, a net change of 0 holders.
- The largest OncoSec Medical Incorporated buyer in Q3 2017 was Zurich Cantonal Bank, an estimated $93.4K added.
- The largest OncoSec Medical Incorporated seller in Q3 2017 was Millennium Management, an estimated $279K sold.
Based on aggregated 13F filings for Q3 2017.